skip to content

Office for Translational Research

Activities - COVID-19

During the COVID-19 pandemic, the OTR has redirected significant resource to support the research efforts of both the University of Cambridge and CUHP against the disease. Find below the list of activities we have been involved in and the type of support we provide for each. If you require our services, please contact any member of our team. Contact details can be found on The Team page.

COVID-19 Activities:

  • Project management in the following clinical trials
    • RECOVERY: we provided logistical support to get the trial up and running before handing over to the clinical team.
    • TACTIC-E and TACTIC-R: These trials aim to test immuno-modulators to prevent severe organ failure and death in COVID-19 patients. We have been providing general project management by liaising with different stakeholders including NHS Trusts, NIHR, industry and national funding bodies as well as supporting trial communications and website development providing easily-accessible trial information for patients and site staff.
    • PROLIFIC trial: The aim of this trial is to test a prophylactic treatment for COVID-19 for healthcare workers. We have been supporting the team in establishing contacts within the wider biomedical/healthcare community in order to make the trial as accessible as possible to all healthcare professionals.
  • Translating Research
    • We have been maintaining an up-to-date list of COVID-19 funding available for i) basic biomedical research, to better understand  and treat the disease and ii) more translational projects such as clinical trials and public health research
    • In collaboration with other offices in the University, we have redirected some of the OTR-administered MRC CiC translational fund for internal projects towards COVID-19 research. The OTR organised and coordinated the funding call, assessed proposals and distributed funding. We will also follow up on the funded projects within the Clinical School.
  • Funding Partners
    • We have helped external parties to identify and start discussions with the relevant stakeholders in the University and CUHP to advance their project and tackle the disease.
    • We have been working with industry to raise awareness of ongoing COVID-19 research efforts, with the aim of attracting external financial and advisory support (as example: Medtronic).
    • We have supported different projects in accessing suitable funding, including trials such as TACTIC and PROLIFIC.
    • We are actively involved in coordination of the Clinical Initiatives on the UoC_COVID-19 Academic Initiatives Hub (a dedicated channel on MS Teams).